Literature DB >> 33194494

Refractory Kawasaki Disease Presenting With Erythema at Bacille Calmette-Guérin Inoculation Site: A Paediatric Case Report.

Vijayakumary Thadchanamoorthy1, Kavinda Dayasiri2.   

Abstract

Kawasaki disease (KD) is an autoimmune disease that generally affects children under the age of five years. It has a variety of clinical manifestations which may be either specific or nonspecific. Intravenous immunoglobulin and aspirin are the mainstays of treatment. There are unusual circumstances where patients are resistant to conventional treatment. We report a one-year-old girl who presented with a 12-day history of fever in association with erythema at the site of Bacille Calmette-Guérin (BCG) scar. She did not respond successfully to conventional treatment although she was diagnosed to have Kawasaki disease. Eventually, she responded to intravenous methylprednisolone and was diagnosed as having refractory Kawasaki disease.
Copyright © 2020, Thadchanamoorthy et al.

Entities:  

Keywords:  bcg site erythema.; refractory

Year:  2020        PMID: 33194494      PMCID: PMC7659888          DOI: 10.7759/cureus.10928

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

Review 1.  Kawasaki Disease.

Authors:  Jane W Newburger; Masato Takahashi; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

Review 2.  Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.

Authors:  Seyyedeh Saneeymehri; Katherine Baker; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

3.  Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.

Authors:  Hua Zhu; Shao-Fei Yu; Yu-Xin Bai; Yan-Yan Liang; Xue-Wen Su; Jing-Ying Pan
Journal:  Exp Ther Med       Date:  2015-05-11       Impact factor: 2.447

Review 4.  Diagnosis and management of kawasaki disease.

Authors:  Aaron Saguil; Matthew Fargo; Scott Grogan
Journal:  Am Fam Physician       Date:  2015-03-15       Impact factor: 3.292

Review 5.  The role of corticosteroids in the treatment of Kawasaki disease.

Authors:  Ling-Sai Chang; Ho-Chang Kuo
Journal:  Expert Rev Anti Infect Ther       Date:  2020-01-15       Impact factor: 5.091

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  Predicting factors for refractory kawasaki disease.

Authors:  Young-Sun Do; Ki-Won Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

9.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Erythema at BCG Inoculation Site in Kawasaki Disease Patients.

Authors:  Mohammad Sadegh Rezai; Soheila Shahmohammadi
Journal:  Mater Sociomed       Date:  2014-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.